AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2023 Issue 1; Section X - New Technology

Transfusion of New Therapeutic Substances

In Section X, New Technology, table XW1, Transfusion of Anatomical Regions, New Technology value J Exagamglogene Autotemcel was added to body parts 3 Peripheral Vein and 4 Central Vein, to capture the intravenous administration of exagamglogene autotemcel (exa-cel), an autologous ex vivo gene-edited biological product that is used to increase fetal hemoglobin (HbF) in patients with transfusion-dependent beta thalassemia (TDT) and severe sickle cell disease (SCD). HbF is a fetal form of oxygen-carrying hemoglobin that decreases during infancy but transports oxygen more efficiently than adult hemoglobin.First, the patient’s hematopoietic stem cells are harvested from the blood. Exa-cel...

To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .


  • The official AHA publication for ICD-10-CM and ICD-10-PCS coding guidelines and advice
  • Current newsletters added each quarter
  • Full Archives - over 3100 articles
  • ALL years/issues back to 1984 organized by year and issue
  • Includes ICD-10-CM/PCS Articles since 2013
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - ICD-10-CM/PCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.